The Involvement of Peroxiporins and Antioxidant Transcription Factors in Breast Cancer Therapy Resistance

L Milković, M Mlinarić, I Lučić, A Čipak Gašparović - Cancers, 2023 - mdpi.com
Simple Summary The main problem preventing successful cancer treatment is therapy
resistance. Initially, the membrane pumps were identified as the cause of resistance, but …

Co-administration of Rifampicin and Boswellia Serrata Mitigates Testicular Toxicity Caused by Aflatoxin B1

FA Korkak, ZK Alkaç, G Arkalı, İH Güngör, BF Yüksel… - Toxicon, 2025 - Elsevier
The current study was aimed to investigate the effect of rifampicin (Rif), a stimulator of P-
glycoprotein (P-gp) and breast cancer resistance protein (BCRP), on limiting the passage of …

Acetylsalicylic Acid with Ascorbate: A Promising Combination Therapy for Solid Tumors

NM El Ezaby, EA Saad, MA El Basuni - Drugs in R&D, 2024 - Springer
Abstract Background and Objective Cancer is a deadly disease with high mortality rates in
develo** countries. A recent preclinical study found promising results in treating …

Teratogenicity and hepatotoxicity of rifampicin exposure in Zebrafish

Z Rafique, P Adina… - International Journal of …, 2024 - ij-aquaticbiology.com
Antibiotics belong to a large group of pharmaceutical substances that tend to kill or prevent
the growth of bacteria like rifampicin and other antibiotics. The overuse of rifampicin has …